Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables: 2010-2025

Historic Receivables for Rockwell Medical (RMTI) over the last 15 years, with Sep 2025 value amounting to $8.3 million.

  • Rockwell Medical's Receivables fell 6.28% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.4 million, marking a year-over-year decrease of 17.61%. This contributed to the annual value of $8.3 million for FY2024, which is 23.94% down from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Receivables is $8.3 million, which was up 3.02% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Receivables registered a high of $16.2 million during Q2 2022, and its lowest value of $5.4 million during Q2 2023.
  • For the 3-year period, Rockwell Medical's Receivables averaged around $8.8 million, with its median value being $8.9 million (2024).
  • Per our database at Business Quant, Rockwell Medical's Receivables plummeted by 66.56% in 2023 and then surged by 100.33% in 2024.
  • Quarterly analysis of 5 years shows Rockwell Medical's Receivables stood at $11.8 million in 2021, then tumbled by 47.07% to $6.3 million in 2022, then surged by 74.17% to $10.9 million in 2023, then dropped by 23.94% to $8.3 million in 2024, then dropped by 6.28% to $8.3 million in 2025.
  • Its Receivables stands at $8.3 million for Q3 2025, versus $8.1 million for Q2 2025 and $9.7 million for Q1 2025.